Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (7)
  • Open Access

    REVIEW

    Exosomes in viral infection: Effects for pathogenesis and treatment strategies

    FATEMEH HEIDARI1,2, REIHANEH SEYEDEBRAHIMI1,2, PIAO YANG3, MOHSEN ESLAMI FARSANI1,2, SHIMA ABABZADEH2,4, NASER KALHOR5, HAMED MANOOCHEHRI6, MOHSEN SHEYKHHASAN7,*, MARYAM AZIMZADEH8,9,*

    BIOCELL, Vol.47, No.12, pp. 2597-2608, 2023, DOI:10.32604/biocell.2023.043351 - 27 December 2023

    Abstract Exosomes are small vesicles that carry molecules from one cell to another. They have many features that make them interesting for research, such as their stability, low immunogenicity, size of the nanoscale, toxicity, and selective delivery. Exosomes can also interact with viruses in diverse ways. Emerging research highlights the significant role of exosomes in viral infections, particularly in the context of diseases like COVID-19, HIV, HBV and HCV. Understanding the intricate interplay between exosomes and the human immune system holds great promise for the development of effective antiviral therapies. An important aspect is gaining clarity More >

  • Open Access

    VIEWPOINT

    Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients

    SONIA MORETTI, FLAVIA MANCINI, ALESSANDRA BORSETTI*

    BIOCELL, Vol.46, No.12, pp. 2695-2699, 2022, DOI:10.32604/biocell.2022.022257 - 10 August 2022

    Abstract Direct-acting antiviral (DAA) therapies are efficacious for the achievement of sustained virologic response (SVR) in almost all treated hepatitis C virus (HCV)-infected patients. However, the impacts of HCV eradication on immune function and chronic immune activation in the long-term remain controversial and limited, especially in patients co-infected with human immunodeficiency virus (HIV). Indeed, although restoration of many immune responses clearly can be observed, several features of immune perturbations persist over time after HCV clearance. Understanding the degree and reasons of the partial recovery of the immune system in chronic HCV/HIV co-infection after HCV elimination is More >

  • Open Access

    ARTICLE

    Associations between CD133, CK19 and G2/M in cirrhotic HCV (genotype-4) patients with or without accompanying tumor

    Hoda M. EL-EMSHATY1, Entsar A. SAAD2, Mona S. GOUIDA3, Zahraa R. ELSHAHAWY1,2

    BIOCELL, Vol.42, No.2, pp. 55-60, 2018, DOI:10.32604/biocell.2018.07009

    Abstract Hepatitis C virus (HCV)-cirrhotic patients have the highest threat of developing hepatocellular carcinoma (HCC) and may be at risk of extra hepatic cancer. The present study was designed to investigate CD133 and CK19 in HCV (genotype-4)-cirrhotic patients with/without HCC or extra hepatic cancer, to assess the degree of their correlation with cell cycle abnormalities and finally to assess the role of their combination as diagnostic tool for discrimination of cirrhotic patients with HCC from those with extra hepatic cancer. The study included 77 HCV-cirrhotic patients and 20 healthy non-disease control group. Patients were categorized… More >

  • Open Access

    ARTICLE

    An internal control applied to RT-PCR detection of HCV and HIV-1 in human pooled plasma and plasma-derived medicinal products

    Gonzalo RODRÍGUEZ-LOMBARDI1, Luciana REYNA2, María Susana VITALI1, Susana GENTI-RAIMONDI2

    BIOCELL, Vol.39, No.2-3, pp. 15-24, 2015, DOI:10.32604/biocell.2015.39.015

    Abstract A competitive internal control (IC) adapted to RT-PCR in-house assay was developed for HCV RNA detection in human pooled plasma. Also, it was applied in a multiplex RT-PCR for the HIV-1 and HCV RNA screening in human pooled plasma and plasma-derived products. A 258-bp PCR product from the 5´noncoding region of HCV genome was obtained. A competitive IC template was constructed by inserting a 52-bp double strand sequence into the NheI site of the 258-bp amplicon. This sequence was cloned and the obtained plasmid was used to generate a synthetic RNA. The IC/RNA was incorporated… More >

  • Open Access

    ARTICLE

    Serum cytokine levels in patients with hepatocellular carcinoma

    Francesca Capone1, Susan Costantini1, Eliana Guerriero1, Rosa Calemma2, Maria Napolitano2, Stefania Scala2, Francesco Izzo2, Giuseppe Castello1,2

    European Cytokine Network, Vol.21, No.2, pp. 99-104, 2010, DOI:10.1684/ecn.2010.0192

    Abstract The role played by the microenvironment in cancer induction, promotion and progression is crucial. Emerging evidence suggests that cytokines, chemokines and growth factors are major players in carci-nogenesis. Therefore, a detailed understanding of factors and mechanisms associated with the processes leading from inflammation to cancer could improve the therapeutic strategies against this disease. We have used hepatocarcinoma as our model in this study. We evaluated the serum levels of 50 different cytokines, chemo-kines and growth factors in patients affected by HCC with chronic HCV-related hepatitis and liver cirrhosis using multiplex biometric ELISA-based immunoassay. Our data More >

  • Open Access

    ARTICLE

    Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin

    Maria Angeles Jimenez-Sousa1, Raquel Almansa2, Concha de la Fuente1, Agustín Caro-Paton3, Lourdes Ruiz4, Gloria Sanchez-Antolín3, Jose Manuel Gonzalez4, Rocio Aller4, Noelia Alcaide3, Pilar Largo1, Salvador Resino5, Raul Ortiz de Lejarazu6, Jesus F. Bermejo-Martin2

    European Cytokine Network, Vol.21, No.2, pp. 84-91, 2010, DOI:10.1684/ecn.2010.0191

    Abstract Hepatitis C virus causes significant morbidity and mortality worldwide. The infection induces upregulation of cytokine and chemokines commonly linked to the development of cellular and pro-inflammatory antiviral responses. The current standard in hepatitis C treatment consists of combination regimens of pegylated interferon-alpha plus ribavirin. The impact of combined treatment in the host immune response is still poorly understood. In the present study, we profiled 27 cytokines, chemokines and growth factors involved in the innate and adaptive responses to the virus in the serum of 27 hepatitis C virus-infected patients, before and after 12 weeks of… More >

  • Open Access

    ARTICLE

    Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis

    Susan Costantini1, Francesca Capone1, Eliana Guerriero1, Patrizia Maio2, Giovanni Colonna3, Giuseppe Castello1

    European Cytokine Network, Vol.21, No.4, pp. 251-256, 2010, DOI:10.1684/ecn.2010.0214

    Abstract Hepatitis C virus (HCV) infection can present as an acute manifestation, and can lead to severecomplications such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). It represents a globalhealth problem because there is no vaccine currently available. Cytokines play an important role in viralclearance, infection control, inflammation, regeneration and fibrosis, and also are implicated in the pathologicalprocesses occurring in the liver during viral infection. Immunological markers of chronic HCV hepatitis pro-gression as compared to cirrhosis and HCC would be extremely useful, particularly for distinguishing betweenthe molecules produced during HCV-induced chronic inflammation and those secreted during… More >

Displaying 1-10 on page 1 of 7. Per Page